Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Stanford University
Stanford University
Eastern Cooperative Oncology Group
University of Southern California
National Cancer Institute (NCI)
INSYS Therapeutics Inc